Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

A novel class of FKBP12 ligands rescues premature aging phenotypes associated with myotonic dystrophy type 1

  • García Puga, Mikel
  • Gerenu, Gorka
  • Bargiela, Ariadna
  • Espinosa-Espinosa, Jorge
  • Mosqueira-Martín, Laura
  • Sagartzazu-Aizpurua, Maialen
  • Aizpurua, Jesús M.
  • Vallejo-Illarramendi, Ainara
  • Artero, Rubén
  • López de Munain, Adolfo
  • Matheu, Ander
Background: Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder clinically characterized by progressive muscular weakness and multisystem degeneration, which correlates with the size of CTG expansion and MBLN decrease. These changes induce a calcium and redox homeostasis imbalance in several models that recapitulate the features of premature tissue aging. In this study, we characterized the impact of a new family of FKBP12 ligands (generically named MPs or MP compounds) designed to stabilize FKBP12 binding to the ryanodine receptors and normalize calcium dysregulation under oxidative stress. Methods: Human primary fibroblasts from DM1 patients and control donors, treated with MP compounds or not, were used for functional studies of cell viability, proliferation, and metabolism. The gene expression profile in treated cells was determined using RNA sequencing. The impact of MP compounds in vivo was evaluated in a Drosophila model of the disease using locomotor activity and longevity studies. Results: The treatment with different MP compounds reversed oxidative stress and impaired cell viability and proliferation, mitochondrial activity, and metabolic defects in DM1-derived primary fibroblasts. RNA sequencing analysis confirmed the restoration of molecular pathways related to calcium and redox homeostasis and additional pathways, including the cell cycle and metabolism. This analysis also revealed the rescue of alternative splicing events in DM1 fibroblasts treated with MP compounds. Importantly, treatment with MP compounds significantly extended the lifespan and improved the locomotor activity of a Drosophila model of the DM1 disease, and restored molecular defects characteristic of the disease in vivo. Conclusions: Our results revealed that MP compounds rescue multiple premature aging phenotypes described in DM1 models and decipher the benefits of this new family of compounds in the pre-clinical setting of DM1., MG-P and LM-M received a predoctoral fellowship from the University of the Basque Country (PIF 15/245 and PIF19/184, respectively). GG was funded by the Juan de la Cierva-Incorporaci\u00F3n (ISCIII, IJC2019-039965-I) and IKERBASQUE (RF/2023/010) research programs. This work was supported by grants from the Instituto Salud Carlos III and the European Union (PI19/01355, PI21/00557 and PI22/01905), the Health department from Basque Country (2017222021, 2018222021, 2020333008), the Education department from Basque Country (IKUR strategy, NEURODEGENPROT), and the PROMETEO/2020/081 project from the Generalitat Valenciana and CIBERNED funds (CB06/05/1126, Group 609).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

High levels of HDAC expression correlate with microglial aging

  • Auzmendi-Iriarte, Jaione
  • Moreno-Cugnon, Leire
  • Saenz-Antoñanzas, A.
  • Grassi, Daniela
  • Pancorbo, Marian M. de
  • Arévalo, María Ángeles
  • Wood, I.C.
  • Matheu, Ander
Background: Cellular damage gradually accumulates with aging, promoting a time-dependent functional decline of the brain. Microglia play an essential regulatory role in maintaining cognitive activity by phagocytosing cell debris and apoptotic cells during neurogenesis. The activities of different histone deacetylases (HDACs) regulate microglial function during development and neurodegeneration. However, no studies have described the role of HDACs in microglia during physiological aging. Research design and methods: HDAC and microglial marker levels were examined in microglial cells after inducing senescence in vitro and in mouse and human hippocampal biopsies in vivo, using quantitative real-time PCR. Publicly available datasets were used to determine HDAC expression in different brain areas during physiological aging. Results: HDAC expression increased upon the induction of senescence with bleomycin or serial passage in microglial cultures. High levels of HDACs were detected in mice and aged human brain samples. Human hippocampal samples showed a positive correlation between the expression of HDAC1, 3, and 7 and microglial and senescence markers. HDAC1 and 3 levels are enriched in the purified aged microglial population. Conclusions: Several HDACs, particularly HDAC1, are elevated in microglia upon senescence induction in vitro and with aging invivo, and correlate with microglial and senescence biomarkers., J Auzmendi-Iriarte (PRE_2016_1_0375), L Moreno-Cugnon (PRE_2014_1_92) and A Saenz- Antoñanzas (FI17/00250) received predoctoral fellowships from Department of Education, University and Research of the Basque Government and Carlos III Institute, respectively. J Auzmendi-Iriarte received an EMBO Scientific Exchange Grant (number 8775) for developing experiments in the group of IC Wood in the University of Leeds. This work is supported by grants from Instituto de Salud Carlos III co-financed by European Union (PI19/01355, DTS20/00179) and Health Department of the Basque Country.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of a Novel Family of Contilisant + Belinostat Multitarget Small Molecules in Glioblastoma

  • Artetxe-Zurutuza, Aizpea
  • Iturrioz-Rodriguez, Nerea
  • Elizazu, Joseba
  • Garcia-Garcia de Garayo, Raul
  • de Goñi, Irati
  • Vergara, Jhonatan
  • Toledano-Pinedo, Mireia
  • Porro-Pérez, Alicia
  • Azkargorta, Mikel
  • Elortza, Felix
  • Marco-Contelles, José
  • Sampron, Nicolás
  • Matheu, Ander
This article belongs to the Special Issue Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends., [Background:] Glioblastoma is the most common and malignant primary brain tumor in adults, with current treatment presenting limited effectiveness. Therapeutic resistance stems largely from its marked molecular and cellular heterogeneity. Multitarget small molecules (MSMs) have emerged as a promising strategy for treating complex diseases such as cancer. In the present work, we generated a novel family of indole-based MSMs engineered to inhibit histone deacetylases (HDACs), monoamine oxidases (MAOs) and cholinesterases (ChEs) while simultaneously acting as histamine H3 receptor (H3R) antagonists and sigma-1 receptor (S1R) agonists., [Methods:] To accomplish this, we combined selected pharmacophoric moieties from the parent compounds Contilisant and the HDAC pan-inhibitor Belinostat. Nine MSMs were synthesized, [Results:] Most of them showed cytotoxic activity in glioma cells. Among them, three molecules (MTP142, MTP156 and MTP150) were prioritized based on potency; these compounds impaired glioma stem cell (GSC) activity and were predicted to cross the blood–brain barrier. In vivo and multi-omic analyses centered on MTP150 showed significant tumor growth inhibition, both as monotherapy and in combination with temozolomide (TMZ). Transcriptomic and proteomic profiling of patient-derived GSCs revealed MTP150-induced disruption of cell cycle regulation pathways., [Conclusions:] Our data reveal the efficacy of a novel family of MSMs in the pre-clinical setting of glioblastoma., A.A.-Z. received a predoctoral fellowship from the Education Department of the Basque Government (PRE_2020_1_0130). N.I.-R. is the recipient of a Sara Borrell postdoctoral contract (CD22/00076) from the Carlos III Institute of Health. We thank the Histology Platform and Animal Facility of the Biogipuzkoa Health Research Institute for their support. This work was supported by Instituto de Salud Carlos III (ISCIII) through the project PI19/01355, PI22/01905, FORT23-00026, DTS24/00153 and co-funded by the European Union and the Health Department of the Basque Country (2022333034, 2023333012) awarded to A.M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Srr2-dependent SOX2 levels govern the chromatin and transcriptional landscape of adult neural stem cell fate decisions in mouse

  • Cruces-Salguero, Sara
  • Jordán-Pla, Antonio
  • Domingo-Muelas, Ana
  • Morante-Redolat, Jose Manuel
  • Rizzoti, Karine
  • Matheu, Ander
  • Fariñas, Isabel
  • Lovell-Badge, Robin
  • Moncho-Amor, Veronica
21 páginas, 4 figuras, Background: Stem cell maintenance and lineage commitment in the nervous system require precise regulation of transcription factors, with SOX2 serving as a pivotal regulator. SOX2 expression is controlled by multiple enhancers, including the Sox2 regulatory region 2 (Srr2). However, the specific role of Srr2 in adult neurogenesis and chromatin regulation during neural lineage commitment remains incompletely understood. Results: To dissect the function of Srr2, we generate a CRISPR-Cas9 mouse model harboring a targeted deletion of this enhancer. Srr2 deletion reduce SOX2 levels in proliferating, but not differentiating, neurosphere cultures, while impairing both neuronal and oligodendroglial differentiation. Paired bulk RNA-seq and ATAC-seq during proliferation and early differentiation reveal that loss of Srr2 induces widespread chromatin compaction during proliferation, which partially converges toward wild-type states upon early differentiation. Multi-omic integration identifies a subset of neurogenic genes exhibiting persistent promoter closure and impaired transcriptional induction in proliferating mutant cells, despite being normally translated during neural differentiation. In vivo, subependymal zone cells of Srr2del/del mice exhibit lower SOX2 and FOXG1 expression, fewer ASCL1/OLIG2 progenitors, and reduced neuronal and oligodendroglial marker expression. Conclusions: These findings establish Srr2 as a critical enhancer of Sox2 required to maintain a chromatin environment permissive for neural differentiation during stem cell proliferation. Our study underscores the essential role of non-coding regulatory elements in coordinating chromatin accessibility, transcriptional programs, and stem cell fate decisions during adult neurogenesis., Open Access funding provided by The Francis Crick Institute. This work was supported by Instituto de Salud Carlos III (ISCIII) through the project (PI19/01355, PI22/01905, FORT23-00026, DTS24/00153 and PI24/01542) and co-funded by the European Union, and the Health Department of the Basque Country (2022111069, 023333041 and 2024333025). Work at the I.F’s laboratory was supported by grants PID2023-152962NB-I00, CB06/05/0086 (CIBERNED) from Ministerio de Ciencia e Innovación, Prometeo CIPROM/2024/57 from Generalitat Valenciana, and ERC Advanced Grant 101098241 from the European Commission. S.C-S received a predoctoral fellowship from the Ministry of Science, Innovation and Universities (FPU23/01973) and the Spanish Association against Cancer (AECC—PRDGU246336CRUC). V.M-A received a Miguel Servet contract from the Instituto Salud Carlos III (CP23/00111). A.D-M was a recipient of a FPU PhD contract from Ministerio de Educación, Cultura y Deporte (MECD) and her stay at R.L-B’s laboratory was supported by a MECD’s grant included in the FPU program., Peer reviewed